These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17041633)
41. HIV-1/AIDS vaccine development: are we in the darkness. Qiu C; Xu JQ Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210 [No Abstract] [Full Text] [Related]
42. Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals? Rencher SD; Slobod KS; Dawson DH; Lockey TD; Hurwitz JL AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1131-3. PubMed ID: 8554911 [No Abstract] [Full Text] [Related]
43. Current strategies and limitations of HIV vaccines. Kawalekar OU; Shedlock DJ; Weiner DB Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169 [TBL] [Abstract][Full Text] [Related]
44. The genetic basis of resistance to HIV infection and disease progression. Biasin M; De Luca M; Gnudi F; Clerici M Expert Rev Clin Immunol; 2013 Apr; 9(4):319-34. PubMed ID: 23557268 [TBL] [Abstract][Full Text] [Related]
45. New research in HIV immunity points way for vaccine. Rees J Immunotherapy; 2013 May; 5(5):445-6. PubMed ID: 23638739 [No Abstract] [Full Text] [Related]
46. HIV vaccine efficacy trials: A brief history, and options for going forward. McKinnon LR; Card CM; AIDS Rev; 2010; 12(4):209-17. PubMed ID: 21179185 [TBL] [Abstract][Full Text] [Related]
47. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
48. Vaccine to prevent AIDS. Tyring S Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234 [TBL] [Abstract][Full Text] [Related]
49. HIV vaccine development--improving on natural immunity. Johnston MI; Fauci AS N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447 [No Abstract] [Full Text] [Related]
50. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. Loeuillet C; Deutsch S; Ciuffi A; Robyr D; Taffé P; Muñoz M; Beckmann JS; Antonarakis SE; Telenti A PLoS Biol; 2008 Feb; 6(2):e32. PubMed ID: 18288889 [TBL] [Abstract][Full Text] [Related]
51. Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment. Thorball CW; Borghesi A; Bachmann N; Von Siebenthal C; Vongrad V; Turk T; Neumann K; Beerenwinkel N; Bogojeska J; Roth V; Kok YL; Parbhoo S; Wieser M; Böni J; Perreau M; Klimkait T; Yerly S; Battegay M; Rauch A; Schmid P; Bernasconi E; Cavassini M; Kouyos RD; Günthard HF; Metzner KJ; Fellay J; J Acquir Immune Defic Syndr; 2020 Dec; 85(4):517-524. PubMed ID: 33136754 [TBL] [Abstract][Full Text] [Related]
53. Genetics and genomics of infectious disease susceptibility. Hill AV Br Med Bull; 1999; 55(2):401-13. PubMed ID: 10723865 [TBL] [Abstract][Full Text] [Related]
54. Irruption of genomics in the search for disease related genes. Thomas G; Cann H Gut; 2003 May; 52 Suppl 2(Suppl 2):ii1-5. PubMed ID: 12651875 [TBL] [Abstract][Full Text] [Related]
55. Effect of Fc Receptor Genetic Diversity on HIV-1 Disease Pathogenesis. Geraghty DE; Thorball CW; Fellay J; Thomas R Front Immunol; 2019; 10():970. PubMed ID: 31143176 [TBL] [Abstract][Full Text] [Related]
56. Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. van Manen D; van 't Wout AB; Schuitemaker H Retrovirology; 2012 Aug; 9():70. PubMed ID: 22920050 [TBL] [Abstract][Full Text] [Related]